VASO - Vaso Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

Vaso Corporation

137 Commercial Street
Unit 200
Plainview, NY 11803
United States
516-997-4600
http://www.vasocorporation.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees308

Key Executives

NameTitlePayExercisedYear Born
Dr. Jun Ma Ph.D.CEO, Pres & Director472.83kN/A1963
Mr. Michael J. Beecher CPACFO & Sec.246.51kN/A1945
Mr. Peter C. CastleCOO & Director409.35kN/A1968
Mr. Jonathan P. NewtonVP of Fin. & Treasurer202.28kN/A1961
Mr. Shawl B. LobreePres of VasoHealthcare412.51kN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Vaso Corporation operates in the healthcare equipment and information technology industries in the United States and internationally. It operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. It offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for large OEMs into the health provider middle market. Its offerings include General Electric Healthcare (GEHC) diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and enhanced external counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service and training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was founded in 1987 and is headquartered in Plainview, New York.

Corporate Governance

Vaso Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.